Stable salt and crystal forms of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2- dimethylpropyl)-1h-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol

Stable salt and crystal forms of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2- dimethylpropyl)-1h-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol

A salt of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2-dimethylpropyl)-1H-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol with an acid, wherein the acid is selected from the group consisting of hydrochloric acid (HCl), maleic acid, and methanesulfonic acid; a crystalline form of the salt; a pharm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WALKER Tracy, INAMI Yukari, OKUMURA Yoshiyuki
Format: Patent
Sprache:eng ; heb
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator WALKER Tracy
INAMI Yukari
OKUMURA Yoshiyuki
description A salt of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2-dimethylpropyl)-1H-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol with an acid, wherein the acid is selected from the group consisting of hydrochloric acid (HCl), maleic acid, and methanesulfonic acid; a crystalline form of the salt; a pharmaceutical composition comprising the salt; a pharmaceutical composition comprising the crystalline form; a method for preventing or treating a disorder or condition comprising administering the salt; and a process for preparing a pharmaceutically acceptable salt.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IL301333A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IL301333A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IL301333A3</originalsourceid><addsrcrecordid>eNqFizEKwkAQRdNYiHoF2TKBDLhZPICIomCnXRAZzQQXJjshuxaJeAsPbBStrf7j__eH0XMf8MykPHJQ6Ap1aVofkFUpTeWVlCqD3EB815BnEBe2onBtGSvrJPngEfo-SzNQv7FupG45AX0FnRo4k-uksNgJwxxafvgbl-J6AzsKtrAOdF8f-y--UXgcDUpkT5NvjqLpenVYboBqOZGv8UKOwmm7MzNtjFmYv8ILh0dLlg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Stable salt and crystal forms of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2- dimethylpropyl)-1h-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol</title><source>esp@cenet</source><creator>WALKER Tracy ; INAMI Yukari ; OKUMURA Yoshiyuki</creator><creatorcontrib>WALKER Tracy ; INAMI Yukari ; OKUMURA Yoshiyuki</creatorcontrib><description>A salt of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2-dimethylpropyl)-1H-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol with an acid, wherein the acid is selected from the group consisting of hydrochloric acid (HCl), maleic acid, and methanesulfonic acid; a crystalline form of the salt; a pharmaceutical composition comprising the salt; a pharmaceutical composition comprising the crystalline form; a method for preventing or treating a disorder or condition comprising administering the salt; and a process for preparing a pharmaceutically acceptable salt.</description><language>eng ; heb</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230501&amp;DB=EPODOC&amp;CC=IL&amp;NR=301333A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230501&amp;DB=EPODOC&amp;CC=IL&amp;NR=301333A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WALKER Tracy</creatorcontrib><creatorcontrib>INAMI Yukari</creatorcontrib><creatorcontrib>OKUMURA Yoshiyuki</creatorcontrib><title>Stable salt and crystal forms of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2- dimethylpropyl)-1h-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol</title><description>A salt of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2-dimethylpropyl)-1H-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol with an acid, wherein the acid is selected from the group consisting of hydrochloric acid (HCl), maleic acid, and methanesulfonic acid; a crystalline form of the salt; a pharmaceutical composition comprising the salt; a pharmaceutical composition comprising the crystalline form; a method for preventing or treating a disorder or condition comprising administering the salt; and a process for preparing a pharmaceutically acceptable salt.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFizEKwkAQRdNYiHoF2TKBDLhZPICIomCnXRAZzQQXJjshuxaJeAsPbBStrf7j__eH0XMf8MykPHJQ6Ap1aVofkFUpTeWVlCqD3EB815BnEBe2onBtGSvrJPngEfo-SzNQv7FupG45AX0FnRo4k-uksNgJwxxafvgbl-J6AzsKtrAOdF8f-y--UXgcDUpkT5NvjqLpenVYboBqOZGv8UKOwmm7MzNtjFmYv8ILh0dLlg</recordid><startdate>20230501</startdate><enddate>20230501</enddate><creator>WALKER Tracy</creator><creator>INAMI Yukari</creator><creator>OKUMURA Yoshiyuki</creator><scope>EVB</scope></search><sort><creationdate>20230501</creationdate><title>Stable salt and crystal forms of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2- dimethylpropyl)-1h-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol</title><author>WALKER Tracy ; INAMI Yukari ; OKUMURA Yoshiyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IL301333A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; heb</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WALKER Tracy</creatorcontrib><creatorcontrib>INAMI Yukari</creatorcontrib><creatorcontrib>OKUMURA Yoshiyuki</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WALKER Tracy</au><au>INAMI Yukari</au><au>OKUMURA Yoshiyuki</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Stable salt and crystal forms of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2- dimethylpropyl)-1h-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol</title><date>2023-05-01</date><risdate>2023</risdate><abstract>A salt of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2-dimethylpropyl)-1H-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol with an acid, wherein the acid is selected from the group consisting of hydrochloric acid (HCl), maleic acid, and methanesulfonic acid; a crystalline form of the salt; a pharmaceutical composition comprising the salt; a pharmaceutical composition comprising the crystalline form; a method for preventing or treating a disorder or condition comprising administering the salt; and a process for preparing a pharmaceutically acceptable salt.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; heb
recordid cdi_epo_espacenet_IL301333A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Stable salt and crystal forms of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2- dimethylpropyl)-1h-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T11%3A28%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WALKER%20Tracy&rft.date=2023-05-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIL301333A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true